Molecular characterization of HIV-1 Nef and ACOT8 interaction: Insights from in silico structural predictions and in vitro functional assays

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Serena, Michela ^a   Giorgetti, Alejandro ^a   Busato, Mirko ^a   Gasparini, Francesca ^a   Diani, Erica ^a   Romanelli, Maria Grazia ^a   Zipeto, Donato ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACOT8 PROTEIN, HUMAN; LYSINE; NEF PROTEIN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; PALMITOYL COENZYME A HYDROLASE; PROTEIN BINDING;

CELL LINE; GENE DELETION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MOLECULAR MODEL; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN ENGINEERING;

CELL LINE; HIV-1; HUMANS; LYSINE; MODELS, MOLECULAR; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PALMITOYL-COA HYDROLASE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN INTERACTION DOMAINS AND MOTIFS; SEQUENCE DELETION;

EID: 84959504401     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22319     Document Type: Article

References (60)

1. Kestler, H. W., 3rd et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662 (1991).
2. Deacon, N. J. et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991 (1995).
3. Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L. & Desrosiers, R. C. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332, 228-232 (1995).
4. Salvi, R. et al. Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J Virol 72, 3646-3657 (1998).
5. Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C. & Feinberg, M. B. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 179, 101-113 (1994).
6. Spina, C. A., Kwoh, T. J., Chowers, M. Y., Guatelli, J. C. & Richman, D. D. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med 179, 115-123 (1994).
7. Iafrate, A. J., Bronson, S. & Skowronski, J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J 16, 673-684 (1997).
8. Skowronski, J., Parks, D. & Mariani, R. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J 12, 703-713 (1993).
9. Swingler, S. et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 5, 997-103 (1999).
10. Qiao, X. et al. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat Immunol 7, 302-310 (2006).
11. Garcia, J. V. & Miller, A. D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511 (1991).
12. Lama, J., Mangasarian, A. & Trono, D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef-and Vpu-inhibitable manner. Curr Biol 9, 622-631 (1999).
13. Ross, T. M., Oran, A. E. & Cullen, B. R. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol 9, 613-621 (1999).
14. Cohen, G. B. et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIVinfected cells from NK cells. Immunity 10, 661-671 (1999).
15. Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401 (1998).
16. Le Gall, S. et al. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483-495 (1998).
17. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J. M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2, 338-342 (1996).
18. Zipeto, D. & Beretta, A. HLA-C and HIV-1: Friends or Foes? Retrovirology 9, 39 (2012).
19. Chaudhuri, R., Lindwasser, O. W., Smith, W. J., Hurley, J. H. & Bonifacino, J. S. Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor. J Virol 81, 3877-3890 (2007).
20. Bentham, M., Mazaleyrat, S. & Harris, M. Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J Gen Virol 87, 563-571 (2006).
21. Wang, J. K., Kiyokawa, E., Verdin, E. & Trono, D. The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc Natl Acad Sci USA 97, 394-399 (2000).
22. Arold, S. et al. Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein. Protein Sci 9, 1137-1148 (2000).
23. Kienzle, N., Freund, J., Kalbitzer, H. R. & Mueller-Lantzsch, N. Oligomerization of the Nef protein from human immunodeficiency virus (HIV) type 1. Eur J Biochem 214, 451-457 (1993).
24. Liu, L. X. et al. Binding of HIV-1 Nef to a novel thioesterase enzyme correlates with Nef-mediated CD4 down-regulation. J Biol Chem 272, 13779-13785 (1997).
25. Watanabe, H. et al. A novel acyl-CoA thioesterase enhances its enzymatic activity by direct binding with HIV Nef. Biochem Biophys Res Commun 238, 234-239 (1997).
26. Jones, J. M., Nau, K., Geraghty, M. T., Erdmann, R. & Gould, S. J. Identification of peroxisomal acyl-CoA thioesterases in yeast and humans. J Biol Chem 274, 9216-9223 (1999).
27. Miura, S. et al. Carboxyl-terminal consensus Ser-Lys-Leu-related tripeptide of peroxisomal proteins functions in vitro as a minimal peroxisome-targeting signal. J Biol Chem 267, 14405-14411 (1992).
28. Hunt, M. C., Solaas, K., Kase, B. F. & Alexson, S. E. Characterization of an acyl-coA thioesterase that functions as a major regulator of peroxisomal lipid metabolism. J Biol Chem 277, 1128-1138 (2002).
29. Li, J., Derewenda, U., Dauter, Z., Smith, S. & Derewenda, Z. S. Crystal structure of the Escherichia coli thioesterase II, a homolog of the human Nef binding enzyme. Nat Struct Biol 7, 555-559 (2000).
30. Cohen, G. B., Rangan, V. S., Chen, B. K., Smith, S. & Baltimore, D. The human thioesterase II protein binds to a site on HIV-1 Nef critical for CD4 down-regulation. J Biol Chem 275, 23097-23105 (2000).
31. Liu, L. X. et al. Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. J Virol 74, 5310-5319 (2000).
32. Alvarez, E., Girones, N. & Davis, R. J. Inhibition of the receptor-mediated endocytosis of diferric transferrin is associated with the covalent modification of the transferrin receptor with palmitic acid. J Biol Chem 265, 16644-16655 (1990).
33. Barker, P. A., Barbee, G., Misko, T. P. & Shooter, E. M. The low affinity neurotrophin receptor, p75LNTR, is palmitoylated by thioester formation through cysteine 279. J Biol Chem 269, 30645-30650 (1994).
34. Eason, M. G., Jacinto, M. T., Theiss, C. T. & Liggett, S. B. The palmitoylated cysteine of the cytoplasmic tail of alpha 2A-adrenergic receptors confers subtype-specific agonist-promoted downregulation. Proc Natl Acad Sci USA 91, 11178-11182 (1994).
35. Waheed, A. A. & Freed, E. O. Lipids and membrane microdomains in HIV-1 replication. Virus Res 143, 162-176 (2009).
36. Rothman, J. E. Mechanisms of intracellular protein transport. Nature 372, 55-63 (1994).
37. Benichou, S. et al. Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J Biol Chem 269, 30073-30076 (1994).
38. Soding, J., Biegert, A. & Lupas, A. N. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res 33, W244-248 (2005).
39. Gondim, M. V. et al. AP-2 is the crucial clathrin adaptor protein for CD4 downmodulation by HIV-1 Nef in primary infected CD4 + T cells. J Virol 89, 12518-12524 (2015).
40. Schaefer, M. R., Wonderlich, E. R., Roeth, J. F., Leonard, J. A. & Collins, K. L. HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells. PLoS Pathog 4, e1000131 (2008).
41. Schwartz, O., Marechal, V., Friguet, B., Arenzana-Seisdedos, F. & Heard, J. M. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J Virol 72, 3845-3850 (1998).
42. Lucchiari-Hartz, M. et al. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes. J Exp Med 191, 239-252 (2000).
43. da Silva, J. & Hughes, A. L. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1). Mol Biol Evol 15, 1259-1268 (1998).
44. Low, H. et al. Lipid Metabolism in Patients Infected with Nef-deficient HIV-1 Strain. Atherosclerosis 244, 22-28 (2016).
45. Baker, D. & Sali, A. Protein structure prediction and structural genomics. Science 294, 93-96 (2001).
46. Eswar, N., Eramian, D., Webb, B., Shen, M. Y. & Sali, A. Protein structure modeling with MODELLER. Methods Mol Biol 426, 145-159 (2008).
47. Tramontano, A., Cozzetto, D., Giorgetti, A. & Raimondo, D. The assessment of methods for protein structure prediction. Methods Mol Biol 413, 43-57 (2008).
48. Pei, J., Kim, B. H., Tang, M. & Grishin, N. V. PROMALS web server for accurate multiple protein sequence alignments. Nucleic Acids Res 35, W649-652 (2007).
49. Soding, J. Protein homology detection by HMM-HMM comparison. Bioinformatics 21, 951-960 (2005).
50. Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res 42, W320-324 (2014).
51. Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 98, 10037-10041 (2001).
52. de Vries, S. J. & Bonvin, A. M. CPORT: a consensus interface predictor and its performance in prediction-driven docking with HADDOCK. PloS one 6, e17695 (2011).
53. de Vries, S. J. et al. HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets. Proteins 69, 726-733 (2007).
54. Dominguez, C., Boelens, R. & Bonvin, A. M. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125, 1731-1737 (2003).
55. Brunger, A. T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54, 905-921 (1998).
56. Jorgensen, W. & Tirado-Rives, J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc 110, 1657-1666 (1988).
57. Pettersen, E. F. et al. UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612 (2004).
58. Pizzato, M. et al. Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proc Natl Acad Sci USA 104, 6812-6817 (2007).
59. Oppici, E., Roncador, A., Montioli, R., Bianconi, S. & Cellini, B. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase. Biochim Biophys Acta 1832, 2277-2288 (2013).
60. Diani, E. et al. HTLV-1 Tax protein recruitment into IKKepsilon and TBK1 kinase complexes enhances IFN-I expression. Virology 476, 92-99 (2015).